by Symmetron | Jan 21, 2019
Rheumatoid arthritis Tocilizumab in methotrexate-naïve rheumatoid arthritis: a cost-utility model for Slovakia Value in Health. 2015;18(7):A648 Authors Chang S, Sawyer L, Dejonckheere F, Grichova L, Diamantopoulos A Process \ A \ B \ C Publications in...
Recent Comments